1. Home
  2. BGC vs BHVN Comparison

BGC vs BHVN Comparison

Compare BGC & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGC
  • BHVN
  • Stock Information
  • Founded
  • BGC 1945
  • BHVN 2013
  • Country
  • BGC United States
  • BHVN United States
  • Employees
  • BGC N/A
  • BHVN N/A
  • Industry
  • BGC Investment Bankers/Brokers/Service
  • BHVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BGC Finance
  • BHVN Health Care
  • Exchange
  • BGC Nasdaq
  • BHVN Nasdaq
  • Market Cap
  • BGC 4.6B
  • BHVN 5.4B
  • IPO Year
  • BGC 1999
  • BHVN 2017
  • Fundamental
  • Price
  • BGC $10.40
  • BHVN $44.39
  • Analyst Decision
  • BGC Buy
  • BHVN Strong Buy
  • Analyst Count
  • BGC 1
  • BHVN 13
  • Target Price
  • BGC $12.00
  • BHVN $63.42
  • AVG Volume (30 Days)
  • BGC 3.5M
  • BHVN 725.9K
  • Earning Date
  • BGC 10-31-2024
  • BHVN 11-12-2024
  • Dividend Yield
  • BGC 0.77%
  • BHVN N/A
  • EPS Growth
  • BGC 568.68
  • BHVN N/A
  • EPS
  • BGC 0.24
  • BHVN N/A
  • Revenue
  • BGC $2,119,639,000.00
  • BHVN N/A
  • Revenue This Year
  • BGC $17.19
  • BHVN N/A
  • Revenue Next Year
  • BGC $10.16
  • BHVN $179.00
  • P/E Ratio
  • BGC $42.99
  • BHVN N/A
  • Revenue Growth
  • BGC 13.11
  • BHVN N/A
  • 52 Week Low
  • BGC $6.09
  • BHVN $26.80
  • 52 Week High
  • BGC $11.79
  • BHVN $62.21
  • Technical
  • Relative Strength Index (RSI)
  • BGC 54.00
  • BHVN 33.48
  • Support Level
  • BGC $9.06
  • BHVN $51.80
  • Resistance Level
  • BGC $11.79
  • BHVN $54.53
  • Average True Range (ATR)
  • BGC 0.40
  • BHVN 2.42
  • MACD
  • BGC 0.01
  • BHVN -0.92
  • Stochastic Oscillator
  • BGC 49.08
  • BHVN 9.80

About BGC BGC Group Inc.

BGC Group Inc is a brokerage and financial technology company that serves the global financial markets, energy and commodities markets. Its service and product offerings include brokerage for a wide range of financial products including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically the company generates revenue from Asia, Other Europe/MEA, France, Other Americas with the majority of its revenue coming from United Kingdom followed by the United States.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: